Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US1510201049
Ticker CELG
Company CELGENE
Currency $
Price
Aware Investor Index (AII) 0.0574
Recommendation SELL
P/E 122.30
ROE 13.93 %
Capitalization 100,835,776,000 $
Dividend Yield 0.00 %
P/S 10.89
AII Position 531
P/E Position 733
ROE Position 278
Capitalization Position 82
Dividend Yield Position 629
Sales 9,256,000,000 $
10-Year Average Earnings 824,515,000 $
Shares Outstanding 824,900,000
Equity 5,919,000,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
CELGENE Investor Relations Web Site http://ir.celgene.com







Sales:

YEAR MONTH AMOUNT
2015 12 9,256,000,000.00 $
2014 12 7,670,400,000.00 $
2013 12 6,493,900,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 1,602,000,000.00 $
2014 12 1,999,900,000.00 $
2013 12 1,449,900,000.00 $
2012 12 1,456,180,000.00 $
2011 12 1,318,150,000.00 $
2010 12 880,512,000.00 $
2009 12 776,747,000.00 $
2008 12 -1,533,653,000.00 $
2007 12 226,433,000.00 $
2006 12 68,981,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 5,919,000,000.00 $
2014 12 6,524,800,000.00 $
2013 12 5,589,900,000.00 $
2012 12 5,694,467,000.00 $
2011 12 5,512,727,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 824,900,000
2014 12 836,000,000
2013 12 430,300,000
2012 12 440,796,000
2011 12 422,987,284

 












Bloomberg News for CELGENE:

May 18, 2018
We're Shrugging Off Another Batch of Ugly Earnings: Taking Stock
analyst meetings from PYPL (after just announcing a $2.2b purchase of IZettle), chip darling MU, and CELG, which boasts one of the uglier charts in large-cap biotech land.There are also two huge conferences...
May 4, 2018
In Awe of Apple’s Huge Week and Europe Bank Whiffs: Taking Stock
EventsToday -- PTLA Pdufa for AndexXa resubmitted NDA7:00am -- GOGO, RUTH earnings7:30am -- CBOE, CELG earnings; BABA earnings call8:00am -- AXL, LNG, AGIO earnings8:00am -- NCLH investor conference8:30am...
Feb 21, 2018
Sell Side Says Chill Out on Alarming Yield Talk: Taking Stock
GD, HON, MMM, UTX and a bunch of railsHealthcare: RBC hosts an event with names such as CAH, CELG, DVAX (also awaiting update from CDC on Heplisav-B today), GILD, INCY, JNJ, RVNCEnergy: EnerCom...
Aug 4, 2010
Arbitrage Profit in U.S. Takeovers Pending on Aug. 4
08/25/10 ARG US APD US 63.50 65.30 -1.80 -2.76 77,416 Cash 08/13/10 ABII US CELG US 72.75 75.78 -3.03 -3.99 2,776 C&S 12/31/10 CASY US ATD/B CN 36.75 ...
Feb 10, 2012
Nasdaq Short Interest as of Jan. 31
642 5,536 CECE CECO ENVIRONMNTL 6,147 7,504 31,975 CELG CELGENE CORP 7,920,994 9,159,230 3,595,048 CELGZ CELGENE CORP-CVR...
Jan 21, 2011
S&P 500 Stocks With Biggest Gap Between Market Price, Estimate
15.30 19.39 -8.43 BAC BANK OF AMERICA 26.4 23 14.34 18.13 -11.57 CELG CELGENE CORP 26.2 22 56.37 71.14 -2.40 GME GAMESTOP CORP-A 25...
Jan 7, 2011
S&P 500 Stocks With Biggest Gap Between Market Price, Estimate
46.18 55.88 -2.48 JPM JPMORGAN CHASE 20.8 22 43.28 52.30 1.77 CELG CELGENE CORP 20.8 22 59.34 71.68 4.61 CSCO CISCO SYSTEMS 20...
Apr 26, 2012
Midmorning Negative EPS Surprises for U.S. Companies, April 26
-2.6 0.40 -5.0 Mar UBSI UNITED BANKSHS 0.42 0.44 -4.5 0.44 -4.5 Mar CELG* CELGENE CORP 1.08 0.83 30.1 1.13 -4.4 Mar AET* AETNA INC ...
Apr 26, 2012
U.S. Companies Reporting Negative EPS Surprises, April 26
0.09 1.37 UBSI UNITED BANKSHS 0.42 0.44 -4.5 0.44 -4.5 -0.12 -0.44 CELG* CELGENE CORP 1.08 0.83 30.1 1.13 -4.4 -4.99 -6.41 AET* AETNA INC ...
Jul 28, 2011
Midmorning Positive EPS Surprises for U.S. Companies, July 28
8.5 0.49 4.1 Jun DRE DUKE REALTY CORP 0.29 0.29 0.0 0.28 3.6 Jun CELG* CELGENE CORP 0.89 0.69 29.0 0.86 3.5 Jun K* KELLOGG CO ...


Google News for CELGENE:

Seeking Alpha - 6 days ago
Celgene: Still (Looks) Appealing
Celgene (CELG) has been on my watchlist for a while as its shares continue to lag despite the promise of a rich pipeline, high regard of the ...
StreetInsider.com
Is Celgene's Stock A Buy The Dip Opportunity?
Celgene (CELG) has three key drugs in its late-stage pipeline and yet the market refuses to buy the stock. Bearishness is building up so much ...
Investor's Business Daily
Will 'Public Shaming' Sink Celgene?
The FDA posted a list of companies who have been targets of complaints by generic drug makers. CELG topped the list. CELG's public ...
Seeking Alpha - 5 days ago
Goldman bearish on Celgene
In a note, Goldman Sachs' Terence Flynn (Sell/$81) says Celgene (NASDAQ:CELG) "needs to deliver" on a number of upcoming data readouts ...
Benzinga
Celgene Corporation: How to Effectively Buy Into CELG Stock
After years of growth, Celgene Corporation (NASDAQ:CELG) has spent the past eight months suffering from ever-weakening price action.
Investor's Business Daily
Celgene And Otezla Are Cracking
CELG is down over 25% Y/Y due to questions over its drug pipeline. Price hikes for Revlimid have helped maintain top line growth. Otezla's Q1 ...
Seeking Alpha - 20 May 2018
Celgene (CELG) Announces Additional $3 Billion Buyback and ...
Celgene Corporation (NASDAQ: CELG) today announced that the Company's Board of Directors authorized the repurchase of an additional $3 ...
Seeking Alpha - 2 days ago
Generic Revlimid Could Sink Celgene
MYL and Dr. Reddy's are pushing to offer generic Revlimid. Revlimid represents over 60% of CELG's revenue and is responsible for the lion's ...
Yahoo Finance - 5 days ago
Celgene (CELG) Q1 2018 Results - Earnings Call Transcript
Celgene Corp. (NASDAQ:CELG) Q1 2018 Earnings Call May 4, 2018 9:00 AM ET. Executives. Patrick E. Flanigan III - Celgene Corp.
StockNewsJournal
Celgene Earnings Preview
Celgene (CELG) reports quarterly earnings May 4th. Analysts expect revenue of $3.46 billion and eps of $1.96. The revenue estimate implies a ...


Back